Literature DB >> 14980440

Efficient eukaryotic expression of fluorescent scFv fusion proteins directed against CD antigens for FACS applications.

Matthias Peipp1, Domenica Saul, Karin Barbin, Joerg Bruenke, Susan J Zunino, Michael Niederweis, Georg H Fey.   

Abstract

Two sets of expression vectors were constructed that permitted the efficient expression of single-chain Fv fragments (scFvs) fused N-terminally to an enhanced mutant of the green fluorescent protein GFP+ or the red fluorescent protein DsRed in insect and mammalian cells. The vectors allowed rapid cloning of scFv fragments and secretion of the fusion proteins in a native conformation. Fluorescent scFv fusion proteins directed against a series of cluster of differentiation (CD) antigens were efficiently secreted by transiently transfected mammalian cells and insect cells infected with baculoviral expression constructs. Yields of the secreted proteins varied from 100 microg/l to 3 mg/l. The purified proteins were functionally active in flow cytometry, immunofluorescent microscopy, and competition binding experiments performed to delineate the epitopes recognized by different monoclonal antibodies against the same polypeptide. The use of two different scFv fragments fused with red and green fluorescent proteins and reacting with T- and B-cell lineage markers (CD7 and CD19), respectively, allowed a simplified quantitation of both subsets in two-color flow cytometry experiments with mixed populations of T- and B-lymphoid cells. Due to the lack of Fc domains in the scFv proteins, the fluorescent fusion proteins showed more than 20-fold reduced background fluorescence compared with whole antibodies of the same specificity in experiments with effector cells expressing the high affinity FcgammaRI receptor CD64. Thus, for a number of analytical applications, fluorescent scFv fusion proteins offer advantages over the use of complete primary antibodies and chemically labeled fluorescent secondary antibodies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14980440     DOI: 10.1016/j.jim.2003.12.001

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  8 in total

1.  Module based antibody engineering: a novel synthetic REDantibody.

Authors:  Anatoliy Markiv; Bernard Anani; Ravi V Durvasula; Angray S Kang
Journal:  J Immunol Methods       Date:  2010-11-03       Impact factor: 2.303

2.  A yeast platform for the production of single-chain antibody-green fluorescent protein fusions.

Authors:  Dagang Huang; Eric V Shusta
Journal:  Appl Environ Microbiol       Date:  2006-10-06       Impact factor: 4.792

3.  Conformational targeting of fibrillar polyglutamine proteins in live cells escalates aggregation and cytotoxicity.

Authors:  Erik Kvam; Brent L Nannenga; Min S Wang; Zongjian Jia; Michael R Sierks; Anne Messer
Journal:  PLoS One       Date:  2009-05-28       Impact factor: 3.240

4.  Multiple site-specific in vitro labeling of single-chain antibody.

Authors:  Boopathy Ramakrishnan; Elizabeth Boeggeman; Maria Manzoni; Zhongyu Zhu; Kristin Loomis; Anu Puri; Dimiter S Dimitrov; Pradman K Qasba
Journal:  Bioconjug Chem       Date:  2009-07       Impact factor: 4.774

5.  Baculovirus display of single chain antibody (scFv) using a novel signal peptide.

Authors:  Kuntida Kitidee; Sawitree Nangola; Gaëlle Gonzalez; Pierre Boulanger; Chatchai Tayapiwatana; Saw-See Hong
Journal:  BMC Biotechnol       Date:  2010-11-19       Impact factor: 2.563

6.  Expression of recombinant multi-coloured fluorescent antibodies in gor -/trxB- E. coli cytoplasm.

Authors:  Anatoliy Markiv; Richard Beatson; Joy Burchell; Ravi V Durvasula; Angray S Kang
Journal:  BMC Biotechnol       Date:  2011-11-30       Impact factor: 2.563

7.  Novel application of anti-human Fc nanobody for screening high-producing CHO cells for monoclonal antibody.

Authors:  Di Zhu; Zheng Wang; Yunxia Xu; Jing Lin; Mei Qiu; Jianghai Liu; Xinlei Li
Journal:  Eng Life Sci       Date:  2022-08-23       Impact factor: 3.405

8.  CD19 and CD20 targeted vectors induce minimal activation of resting B lymphocytes.

Authors:  Sabrina Kneissl; Qi Zhou; Michael Schwenkert; François-Loic Cosset; Els Verhoeyen; Christian J Buchholz
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.